309 related articles for article (PubMed ID: 30032344)
1. Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.
Harquail J; LeBlanc N; Landry C; Crapoulet N; Robichaud GA
J Mammary Gland Biol Neoplasia; 2018 Sep; 23(3):177-187. PubMed ID: 30032344
[TBL] [Abstract][Full Text] [Related]
2. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
Wu H; Wang G; Wang Z; An S; Ye P; Luo S
FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
[TBL] [Abstract][Full Text] [Related]
3. miRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer cells.
Harquail J; LeBlanc N; Ouellette RJ; Robichaud GA
Carcinogenesis; 2019 Aug; 40(8):1010-1020. PubMed ID: 30605519
[TBL] [Abstract][Full Text] [Related]
4. Pax-5 Inhibits Breast Cancer Proliferation Through MiR-215 Up-regulation.
Leblanc N; Harquail J; Crapoulet N; Ouellette RJ; Robichaud GA
Anticancer Res; 2018 Sep; 38(9):5013-5026. PubMed ID: 30194145
[TBL] [Abstract][Full Text] [Related]
5. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.
Benzina S; Beauregard AP; Guerrette R; Jean S; Faye MD; Laflamme M; Maïcas E; Crapoulet N; Ouellette RJ; Robichaud GA
Oncotarget; 2017 Feb; 8(7):12052-12066. PubMed ID: 28076843
[TBL] [Abstract][Full Text] [Related]
6. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.
Eddy SF; Guo S; Demicco EG; Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2005 Dec; 65(24):11375-83. PubMed ID: 16357145
[TBL] [Abstract][Full Text] [Related]
7. Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells.
Qin B; Cheng K
Breast Cancer Res; 2010; 12(5):R74. PubMed ID: 20863366
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-708 activation by glucocorticoid receptor agonists regulate breast cancer tumorigenesis and metastasis via downregulation of NF-κB signaling.
Senthil Kumar KJ; Gokila Vani M; Hsieh HW; Lin CC; Liao JW; Chueh PJ; Wang SY
Carcinogenesis; 2019 Apr; 40(2):335-348. PubMed ID: 30726934
[TBL] [Abstract][Full Text] [Related]
9. IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.
House CD; Grajales V; Ozaki M; Jordan E; Wubneh H; Kimble DC; James JM; Kim MK; Annunziata CM
BMC Cancer; 2018 May; 18(1):595. PubMed ID: 29801480
[TBL] [Abstract][Full Text] [Related]
10. FOXP3 Controls an miR-146/NF-κB Negative Feedback Loop That Inhibits Apoptosis in Breast Cancer Cells.
Liu R; Liu C; Chen D; Yang WH; Liu X; Liu CG; Dugas CM; Tang F; Zheng P; Liu Y; Wang L
Cancer Res; 2015 Apr; 75(8):1703-13. PubMed ID: 25712342
[TBL] [Abstract][Full Text] [Related]
11. IKKε regulates the breast cancer stem cell phenotype.
Orlova Z; Pruefer F; Castro-Oropeza R; Ordaz-Ramos A; Zampedri C; Maldonado V; Vazquez-Santillan K; Melendez-Zajgla J
Biochim Biophys Acta Mol Cell Res; 2019 Apr; 1866(4):598-611. PubMed ID: 30615901
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of RPA2 promotes NF-κB activation in breast cancer by relieving the antagonistic function of menin on NF-κB-regulated transcription.
Chen CC; Juan CW; Chen KY; Chang YC; Lee JC; Chang MC
Carcinogenesis; 2017 Feb; 38(2):196-206. PubMed ID: 28007956
[TBL] [Abstract][Full Text] [Related]
13. Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
Boehm JS; Zhao JJ; Yao J; Kim SY; Firestein R; Dunn IF; Sjostrom SK; Garraway LA; Weremowicz S; Richardson AL; Greulich H; Stewart CJ; Mulvey LA; Shen RR; Ambrogio L; Hirozane-Kishikawa T; Hill DE; Vidal M; Meyerson M; Grenier JK; Hinkle G; Root DE; Roberts TM; Lander ES; Polyak K; Hahn WC
Cell; 2007 Jun; 129(6):1065-79. PubMed ID: 17574021
[TBL] [Abstract][Full Text] [Related]
14. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
[TBL] [Abstract][Full Text] [Related]
15. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
[TBL] [Abstract][Full Text] [Related]
16. MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-κB Pathway.
Wang L; Guo S; Zhang H
Technol Cancer Res Treat; 2017 Dec; 16(6):1226-1234. PubMed ID: 29333957
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
[TBL] [Abstract][Full Text] [Related]
19. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis.
Wang H; Xiao Y; Wu L; Ma D
Int J Oncol; 2018 Mar; 52(3):743-754. PubMed ID: 29431182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
